| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.CCM.0000126263.00551.06 |
| P698 | PubMed publication ID | 15190968 |
| P2093 | author name string | Philippe Karoubi | |
| Yves Cohen | |||
| Christophe Clec'h | |||
| Michel Cupa | |||
| Françoise Ferriere | |||
| Jean P Fosse | |||
| Philippe Hoang | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| sepsis | Q183134 | ||
| septic shock | Q1765564 | ||
| P304 | page(s) | 1166-1169 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Critical Care Medicine | Q5186605 |
| P1476 | title | Diagnostic and prognostic value of procalcitonin in patients with septic shock | |
| P478 | volume | 32 |
| Q36743345 | Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. |
| Q54222362 | Acute encephalopathy with biphasic seizures and late reduced diffusion associated with Streptococcus sanguinis sepsis |
| Q38676048 | Altered levels of soluble CD18 may associate immune mechanisms with outcome in sepsis. |
| Q36165942 | Beyond sepsis pathophysiology with cytokines: what is their value as biomarkers for disease severity? |
| Q34094906 | Biomarkers of acute lung injury: worth their salt? |
| Q54516948 | Canine procalcitonin messenger RNA expression. |
| Q28547939 | Clinical Usefulness of Procalcitonin and C-Reactive Protein as Outcome Predictors in Critically Ill Patients with Severe Sepsis and Septic Shock |
| Q39516537 | Clinical significance of ischemia modified albumin in critically ill patients with sepsis |
| Q38387886 | Delta Procalcitonin Is a Better Indicator of Infection Than Absolute Procalcitonin Values in Critically Ill Patients: A Prospective Observational Study |
| Q40021612 | Delta neutrophil index: could it predict mortality in patients with bacteraemia? |
| Q61757070 | Diagnose und Therapie der Sepsis |
| Q44754456 | Diagnosis and therapy of sepsis |
| Q34001903 | Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients |
| Q40126380 | Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. |
| Q46153485 | Diagnostic utility of LightCycler SeptiFast and procalcitonin assays in the diagnosis of bloodstream infection in immunocompromised patients |
| Q51105094 | Diagnostic value of sTREM-1 and procalcitonin levels in the early diagnosis of sepsis |
| Q41997121 | Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation |
| Q84972542 | Dynamic Change of Procalcitonin, Rather Than Concentration Itself, Is Predictive of Survival in Septic Shock Patients When Beyond 10 ng/mL |
| Q36295952 | Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity |
| Q41350366 | Elevated postoperative serum procalcitonin is not indicative of bacterial infection in cardiac surgical patients |
| Q80079911 | Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock |
| Q43629291 | Evaluation of the Mortality in Emergency Department Sepsis score combined with procalcitonin in septic patients |
| Q42754397 | In Critically Ill Patients, Serum Procalcitonin Is More Useful in Differentiating between Sepsis and SIRS than CRP, Il-6, or LBP. |
| Q59797565 | Inflammatory and coagulatory parameters linked to survival in critically ill children with sepsis |
| Q46681140 | Intra‐hospital transfers to a higher level of care: Contribution to total hospital and intensive care unit (ICU) mortality and length of stay (LOS) |
| Q36931182 | Is there value in plasma cytokine measurements in patients with severe trauma and sepsis? |
| Q33653520 | Kinetics of procalcitonin in cardiogenic shock and in septic shock. Preliminary data |
| Q34013704 | Lipopolysaccharide-binding protein for monitoring of postoperative sepsis: complemental to C-reactive protein or redundant? |
| Q42930048 | Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis? |
| Q59167784 | Meta-analysis of procalcitonin for sepsis detection – Authors' reply |
| Q41903053 | Multiple Biomarkers to Assess the Pathophysiological State in Critically Ill Patients with Sepsis |
| Q38257409 | Overoptimism in the interpretation of statistics: the ethical role of statistical reviewers in medical journals |
| Q44353822 | PCT as a diagnostic and prognostic tool in burn patients. Whether time course has a role in monitoring sepsis treatment |
| Q40052290 | Predicting and managing sepsis in burn patients: current perspectives |
| Q33753353 | Predicting treatment failure in severe sepsis and septic shock: looking for the Holy Grail |
| Q37233472 | Prediction of sepsis in trauma patients |
| Q35561237 | Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study |
| Q30726774 | Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial |
| Q33974292 | Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine |
| Q36067274 | Pro-atrial natriuretic peptide (pro-ANP) level in patients with severe sepsis and septic shock: prognostic and diagnostic significance |
| Q40113813 | Procalcitonin - Assisted Antibiotic Strategy in Sepsis |
| Q54317622 | Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis |
| Q34325775 | Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis |
| Q36582374 | Procalcitonin kinetics - prognostic and diagnostic significance in septic patients |
| Q57554486 | Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia |
| Q37210066 | Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome |
| Q40745926 | Procalcitonin level for prediction of postoperative infection in cardiac surgery |
| Q40174999 | Procalcitonin-Guided Antibiotics after Surgery for Peritonitis: A Randomized Controlled Study. |
| Q81828641 | Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression |
| Q37090231 | Prognostic value of procalcitonin in hospitalized patients with lower respiratory tract infections |
| Q61757039 | Prävention, Diagnose, Therapie und Nachsorge der Sepsis |
| Q38171058 | Rapid diagnosis of sepsis |
| Q61757063 | Sepsis |
| Q83723106 | Sepsis Biomarkers in Polytrauma Patients |
| Q26799911 | Sepsis: From Pathophysiology to Individualized Patient Care |
| Q50044525 | Septic shock in a renal transplanted patient after consumption of uncooked pork meat |
| Q38658077 | Serum Procalcitonin Predicts Anastomotic Leaks in Colorectal Surgery |
| Q27468816 | Serum Procalcitonin and Peripheral Venous Lactate for Predicting Dengue Shock and/or Organ Failure: A Prospective Observational Study |
| Q87603935 | Serum hsCRP and procalcitonin levels in dyspeptic patients infected with CagA-positive Helicobacter pylori |
| Q58999738 | Serum lactate and procalcitonin measurements in emergency room for the diagnosis and risk-stratification of patients with suspected infection |
| Q33325779 | Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria |
| Q34612152 | Serum procalcitonin level and SOFA score at discharge from the intensive care unit predict post-intensive care unit mortality: a prospective study |
| Q36560376 | Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients |
| Q37615793 | Serum soluble triggering receptor expressed on myeloid cells-1 and procalcitonin can reflect sepsis severity and predict prognosis: a prospective cohort study |
| Q36336058 | Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock. |
| Q39486453 | The role of procalcitonin and IL-6 in discriminating between septic and non-septic causes of ALI/ARDS: a prospective observational study |
| Q36331500 | The utility of C-reactive protein and procalcitonin for sepsis diagnosis in critically burned patients: A preliminary study |
| Q36744024 | Treatment of severe sepsis: where next? Current and future treatment approaches after the introduction of drotrecogin alfa |
| Q97524230 | Two gene set variation indexes as potential diagnostic tool for sepsis |
| Q38225139 | Update on procalcitonin measurements |
| Q36026794 | Use of a semiquantitative procalcitonin kit for evaluating severity and predicting mortality in patients with sepsis |
| Q40977186 | Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis |
| Q43700178 | Usefulness of procalcitonin upon admission to intensive care in the diagnosis and prognosis of sepsis |
| Q40482831 | [Procalcitonin as an early marker of sepsis]. |
| Q79547937 | [Septic shock due to vancomycin-resistant enterococci infection. Tigecycline monotherapy] |
| Q91901969 | [The diagnosis of sepsis] |
Search more.